ENGLEWOOD, Colo., June 10, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that it will participate in an analyst-led fireside chat on an RBC Capital Markets 2024 Medical Device Strategy & Innovation Call at 11:00 AM ET on Thursday, June 13, 2024.
Shagun Singh, Medical Supplies & Devices Analyst, RBC Capital Markets and Thomas Sandgaard, Chairman, President, & Chief Executive Officer, Zynex, will participate in the fireside chat.
RBCCM 2024 Medical Device Strategy & Innovation Call: Zynex
Date: Thursday, June 13, 2024
Time: 11:00 AM – 12:00 PM ET
Web Link: https://www.veracast.com/webcasts/rbc/meetings/z71eMX.cfm
Registration for the live event is required. A replay of the webcast will also be available for two weeks following the event.
About Zynex, Inc.
Zynex, founded in 1996, develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser-based pulse oximetry monitoring systems for use in hospitals. For additional information, please visit: www.zynex.com.
Investor Relations Contact:
Quinn Callanan, CFA or Brian Prenoveau, CFA
MZ Group – MZ North America
ZYXI@mzgroup.us
+949 694 9594
SOURCE Zynex
